Merck
CN
Search Within
Document Type

213-181-8

Applied Filters:
Keyword:'213-181-8'
Showing 1-25 of 25 results for "213-181-8" within Technical Documents
Data Sheet - C8206
Trans. R. Soc. Lond. B. Bio. Sci., 354, 289 (1999). 7. Waterman, S.A., Prog. Neurobiol., 60, 181 (2000). 8. Uneyama, H. et al., Int. J. Mol. Med., 3, 455 (1999). 9. Ophoff, R.A. et al., Trends Pharmacol
Data Sheet - M5808
Kähäri, V.M., and Saarialho-Kere, U., Matrix metalloproteinases in skin. Exp. Dermatol., 6, 199- 213 (1997). 4. Halpert, I. et al., Matrilysin is expressed by lipid- laden macrophages at sites of
Data Sheet - M9933
. Kähäri, V.M., and Saarialho-Kere, U., Matrix metalloproteinases in skin. Exp. Dermatol., 6, 199- 213 (1997). 4. Halpert, I., et al., Matrilysin is expressed by lipid- laden macrophages at sites of
XP725 Antibody Number-Lot Number 071M4826
254 255 256 277 278 279 280 3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284 3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288 4.1 289
Product Information Sheet - P2277
1974). 7. Crouch, T. H. et al., Biochem., vol 19, 3692-3698 (1980). 8. Klee, C. and Vanaman, T., Adv. Protein Chem., 35, 213-321 (1982). 9. Means, A. et al., Physiol. Reviews, 62, 1-39 (1982) 10.
Product Information Sheet - CS0680
intima-media thickness: the ECTIM, AXA, EVA and GENIC studies. Europ. J. Hum. Genet. 12, 213-219 (2004). 8. Zhang, J. Y., et al., NF-κ-B RelA opposes epidermal proliferation driven by TNFR1 and JNK
Product Information - CSAA1
Clone:PK-G4 P8083 Signal Transduction M n/d n/d y 212 PKD P3987 Signal Transduction P y y n/d 213 Map Kinase Phosphatase-1 (MKP-1) M3787 Signal Transduction P y n/d n/d 214 Protein phosphatase 1α
Protocol: Rat/Mouse Ghrelin (Active)
296 115% 317 101% 1,000 1,156 109% 1,079 96% Mouse 0 (Basal) 136 -- 213
Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease
He, L., et al., J. Med. Chem., 43, 449-456 (2000). 89. Gilligan, P.J., et al., Bioorg. Med. Chem., 8, 181-189 (2000). 90. Gully, D., et al., J. Pharmacol. Exp. Ther., 301, 322-332 (2002). 91. Okuyama, S.
Research Article: MCP-1, KC-like and IL-8 as critical mediators of
canine babesiosis is associated with a consumptive coagulopathy. Veterinary Journal. 2013; 196(2):213–7. 48. Mackness B, Hine D, Liu YF, Mastorikou M, Mackness M. Paraoxonase-1 inhibits oxidised LDL-induced
Article: Evaluation of immunological parameters in pit bull terrier-type dogs with juvenile onset generalized demodicosis and age-matched healthy pit bull terrier-type dogs
and interleukin-2 receptor expression in dogs with generalized demodicosis. Vet Dermatol 1996; 7: 213–219. 25. Tani K, Morimoto M, Hayashi T et al. Evaluation of cytokine mes- senger RNA expression
User Guide Equinox SOP Software 2.1 for Windows XP
202 202 203 203 203 204 204 205 205 206 206 207 207 208 208 209 209 210 210 210 211 211 213 213 213 214 214 215 215 216 216 Contenido Capítulo 4. Exportar los procedimientos SOP a la
XP725 Antibody List Lot 129K4831
Cathepsin D C0715 1509 CTSD M NP_001900.1 y n/d n/d 146 Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214
XP725 Antibody List Lot 129K4830
Cathepsin D C0715 1509 CTSD M NP_001900.1 y n/d n/d 146 Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214
XP725 Antibody List Lot 089K4791
Cathepsin D C0715 1509 CTSD M NP_001900.1 y n/d n/d 146 Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214
3D BIOPRINTING: Printing a Brighter Future
and biodegradable properties.181 By partial deacetylation of chitin, chitosan is obtained with amine residues that show good anti-bacterial and wound healing performance.181 Chitosan can be readily dissolved
3D BIOPRINTING: Printing a Brighter Future
and biodegradable properties.181 By partial deacetylation of chitin, chitosan is obtained with amine residues that show good anti-bacterial and wound healing performance.181 Chitosan can be readily dissolved
XP725 Worksheet for Lot Number 071M4826
Calretinin C7479 208 2 1 2 8 Calretinin C7479 209 2 1 3 1 Claspin C7867 210 2 1 3 2 Claspin C7867 211 2 1 3 3 CaM Kinase IV CaMKIV C2851 212 2 1 3 4 CaM Kinase IV CaMKIV C2851 213 2 1
inNovations Newsletter #18
Lane M: markers. A. Samples with b-globin, protein S, and HLA DPB1 targets ← 408 bp ← 280 bp ← 213 bp mitochondrial DNA p53 exon 6 p53 exon 11 M 1 2 3 4 N M 1
List of Antibodies
18 C1399 M y n/d n/d 211 Cytokeratin peptide 19 C6930 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 M y n/d n/d 214 phospho-DAPK (pSer308) D4941
Cytoskeletal Signaling Antibodies, Reagents and Kits
.a. 1223-1290 H R IP WB Pur Rb 100 µg AB3882 Anti-phospho-mTOR (Ser2448) M WB APur Rb 100 µg 09-213 siRNA siRNA plasmid, pKD-mTOR-v4, H RNAi 5 mg 62-302 see also GβL, Raptor, Rheb, Sin1 and
XP725 Antibody List 013M4793
Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 1611 DAP NP_004385.1 M y n/d n/d 214 phospho-DAPK (pSer308) D4941
XP725 Antibody List
Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 1611 DAP NP_004385.1 M y n/d n/d 214 phospho-DAPK (pSer308) D4941
Halal Certificate
B23379 HC-23SI1J13 212. 3-(METHYLTHIO)PROPYL ISOTHIOCYANATE 98%, FG W331201 A32483 HC-23SIE869 213. 3,4-DIMETHYL-1,2-CYCLOPENTADIONE 97% W326801 B59475 HC-23SIHC55 214. 3,4-HEXANEDIONE 90% W316814
Halal Certificate
B23379 HC-22SI7U34 212. 3-(METHYLTHIO)PROPYL ISOTHIOCYANATE 98%, FG W331201 A32483 HC-22SI1Z90 213. 3,4-DIMETHYL-1,2-CYCLOPENTADIONE 97% W326801 B59475 HC-22SIDD76 214. 3,4-HEXANEDIONE 90% W316814